Annual Long Term Debt
$327.50 M
-$72.37 M-18.10%
December 31, 2024
Summary
- As of February 26, 2025, TVTX annual long term debt is $327.50 million, with the most recent change of -$72.37 million (-18.10%) on December 31, 2024.
- During the last 3 years, TVTX annual long term debt has risen by +$69.42 million (+26.90%).
- TVTX annual long term debt is now -18.75% below its all-time high of $403.06 million, reached on December 31, 2022.
Performance
TVTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$327.50 M
-$1.04 M-0.32%
December 1, 2024
Summary
- As of February 26, 2025, TVTX quarterly long term debt is $327.50 million, with the most recent change of -$1.04 million (-0.32%) on December 1, 2024.
- Over the past year, TVTX quarterly long term debt has dropped by -$72.37 million (-18.10%).
- TVTX quarterly long term debt is now -19.09% below its all-time high of $404.77 million, reached on March 31, 2022.
Performance
TVTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
TVTX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.1% | -18.1% |
| 3 y3 years | +26.9% | -18.1% |
| 5 y5 years | +59.9% | -18.1% |
TVTX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.8% | +26.9% | -19.1% | +26.9% |
| 5 y | 5-year | -18.8% | +59.9% | -19.1% | +59.9% |
| alltime | all time | -18.8% | +656.6% | -19.1% | +656.6% |
Travere Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $327.50 M(-18.1%) | - |
| Dec 2024 | - | $327.50 M(-0.3%) |
| Sep 2024 | - | $328.54 M(-17.5%) |
| Jun 2024 | - | $398.06 M(-0.2%) |
| Mar 2024 | - | $398.98 M(-0.2%) |
| Dec 2023 | $399.88 M(-0.8%) | $399.88 M(-0.2%) |
| Sep 2023 | - | $400.70 M(-0.2%) |
| Jun 2023 | - | $401.51 M(-0.2%) |
| Mar 2023 | - | $402.30 M(-0.2%) |
| Dec 2022 | $403.06 M(+56.2%) | $403.06 M(-0.1%) |
| Sep 2022 | - | $403.38 M(-0.2%) |
| Jun 2022 | - | $404.05 M(-0.2%) |
| Mar 2022 | - | $404.77 M(+56.8%) |
| Dec 2021 | $258.08 M(+5.9%) | $258.08 M(+15.4%) |
| Sep 2021 | - | $223.70 M(+1.3%) |
| Jun 2021 | - | $220.86 M(+1.3%) |
| Mar 2021 | - | $218.08 M(-10.5%) |
| Dec 2020 | $243.68 M(+18.9%) | $243.68 M(+14.6%) |
| Sep 2020 | - | $212.65 M(+1.3%) |
| Jun 2020 | - | $210.01 M(+1.3%) |
| Mar 2020 | - | $207.41 M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $204.86 M(+5.0%) | $204.86 M(+1.2%) |
| Sep 2019 | - | $202.35 M(+1.2%) |
| Jun 2019 | - | $199.89 M(+1.2%) |
| Mar 2019 | - | $197.47 M(+1.2%) |
| Dec 2018 | $195.09 M(+332.8%) | $195.09 M(+1.2%) |
| Sep 2018 | - | $192.75 M(+326.1%) |
| Mar 2018 | - | $45.24 M(+0.4%) |
| Dec 2017 | $45.08 M(+1.5%) | $45.08 M(+0.4%) |
| Sep 2017 | - | $44.91 M(+0.4%) |
| Jun 2017 | - | $44.75 M(+0.4%) |
| Mar 2017 | - | $44.58 M(+0.4%) |
| Dec 2016 | $44.42 M(+1.5%) | $44.42 M(+0.4%) |
| Sep 2016 | - | $44.26 M(+0.4%) |
| Jun 2016 | - | $44.09 M(+0.4%) |
| Mar 2016 | - | $43.93 M(+0.4%) |
| Dec 2015 | $43.77 M(+1.1%) | $43.77 M(+0.0%) |
| Sep 2015 | - | $43.75 M(+0.4%) |
| Jun 2015 | - | $43.59 M(-48.3%) |
| Mar 2015 | - | $84.24 M(+94.6%) |
| Dec 2014 | $43.29 M | $43.29 M(-48.0%) |
| Sep 2014 | - | $83.29 M(+0.6%) |
| Jun 2014 | - | $82.81 M |
FAQ
- What is Travere Therapeutics annual long term debt?
- What is the all time high annual long term debt for Travere Therapeutics?
- What is Travere Therapeutics annual long term debt year-on-year change?
- What is Travere Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Travere Therapeutics?
- What is Travere Therapeutics quarterly long term debt year-on-year change?
What is Travere Therapeutics annual long term debt?
The current annual long term debt of TVTX is $327.50 M
What is the all time high annual long term debt for Travere Therapeutics?
Travere Therapeutics all-time high annual long term debt is $403.06 M
What is Travere Therapeutics annual long term debt year-on-year change?
Over the past year, TVTX annual long term debt has changed by -$72.37 M (-18.10%)
What is Travere Therapeutics quarterly long term debt?
The current quarterly long term debt of TVTX is $327.50 M
What is the all time high quarterly long term debt for Travere Therapeutics?
Travere Therapeutics all-time high quarterly long term debt is $404.77 M
What is Travere Therapeutics quarterly long term debt year-on-year change?
Over the past year, TVTX quarterly long term debt has changed by -$72.37 M (-18.10%)